| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $27.9M | $27.6M | $26.6M |
| YoY Revenue Growth % | +0.9% | +4.0% | — |
| Gross Profit | $15.4M | $13.4M | — |
| Gross Margin % | 55.2% | 48.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$322.0K | -$777.0K | -$3.4M |
| Operating Margin % | -1.2% | -2.8% | -12.6% |
| Net Income (GAAP) | $3.7M | $661.0K | -$4.0M |
| EBITDA (Normalized) | $382.0K | $501.4K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.5M | -$1.3M | -$2.4M |
| Capital Expenditures (CapEx) | $880.0K | $1.6M | — |
| Free Cash Flow (FCF) | -$6.4M | -$2.9M | -$2.4M |
| FCF Margin % | -22.8% | -10.5% | -8.9% |
| Return on Invested Capital (ROIC %) | -0.5% | -1.6% | — |
| Cash & Short-Term Equivalents | $9.8M | $3.1M | — |
| Total Debt (Short + Long Term) | $18.7M | $29.7M | — |
| Total Stockholders' Equity | $43.5M | $11.7M | — |